A Comparative Evaluation of Pharmacokinetics and Immunogenicity.

Clinical trial NCT06918587 · COMPLETED

Trial details

NCT number: NCT06918587
Sponsor: Kashiv BioSciences, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Febrile Neutropenia

Start date: 2024-09-05
Primary completion: 2025-05-25
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.